Rbf Capital »

Xbiotech shares owned by Rbf Capital

Quarter-by-quarter ownership of Xbiotech (XBIT) shares owned by Rbf Capital from 13F filings

Historical chart of Rbf Capital investment in Xbiotech

Tip: Access up to 7 years of quarterly data

All positions including Xbiotech held by Rbf Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xbiotech by Rbf Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $532k 200k 2.66
2025-06-30 $594k 200k 2.97
2022-09-30 $84k 23k 3.63

More positions owned by Rbf Capital

Morgan Stanley Com New Put Option (MS)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Applovin Corp Com Cl A (APP)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Bank of America Corporation (BAC)
Danaos Corporation SHS (DAC)
Mastercard Incorporated Cl A (MA)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Visa Com Cl A (V)
Hca Holdings (HCA)
Builders FirstSource (BLDR)
Apple (AAPL)
Fair Isaac Corporation (FICO)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Rbf Capital

Top funds holding Xbiotech

Vanguard Group
Millennium Management
BlackRock
Geode Capital Management
Rbf Capital
Morgan Stanley
Northern Trust
State Street Corporation
Dimensional Fund Advisors
Squarepoint Ops
Bridgeway Capital Management
Empowered Funds
Jane Street
Bank of New York Mellon
Citadel Advisors

View all funds holding Xbiotech